Lustre Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2003.
2003 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Lustre Pharmaceuticals Private Limited

Lustre Pharmaceuticals Private Limited, a active private limited company, was established on 24 March 2003 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ2003PTC042154. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Lustre Pharmaceutical Private Limited. It upholds a compliant status. Its leadership includes Jatinkumar Kantilal Modi (Director), Sanjaykumar Babulal Modi (Director), Hirenkumar Knatilal Modi (Director). Past directors included Varishali Faijulhusain Sunsara, Faijulhusain Valibhai Sunsara, Abidhusen Vali Sunsara. It holds ₹6.89 Cr open charges and ₹7.94 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 15, Barcelona Industrial Estate, Sardar Patel Ring Road, Odhav Circle, Od, Hav,, Ahmedabad, Gujarat, 382415.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ2003PTC042154

  • Registration Number

    042154

  • Incorporation Date

    24 March 2003

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 22 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.89 Cr
  • Satisfied Charges ₹ 7.94 Cr
  • Revenue Growth **** 66.54%
  • Profit Growth **** 129.97%
  • Ebitda **** 109.13%
  • Net Worth 22.92%
  • Total Assets **** 15.78%
Company report

Lustre Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lustre Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lustre Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jatinkumar Kantilal Modi Director 24 Mar 2003 Current
Sanjaykumar Babulal Modi Director 20 Jun 2015 Current
Hirenkumar Knatilal Modi Director 24 Mar 2003 Current
Shitalben Sanjykumar Modi Director 24 Mar 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jun 2012 Past
Pramod Abcsdd Director 30 Jun 2012 Past
Pramod Abcsdd Director 01 Apr 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 01 Apr 2010 Past
Pramod Abcsdd Director 01 Apr 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lustre Pharmaceuticals.

Lustre Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 66.54% increase. The company also saw a substantial improvement in profitability, with a 129.97% increase in profit. The company's net worth Soared by an impressive increase of 22.92%.

Lustre Pharmaceuticals revenue growth over time
Lustre Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 66.54%
*******
*******
*******
*******
Revenue from Operations
*******
 66.40%
*******
*******
*******
*******
Total Assets
*******
 15.78%
*******
*******
*******
*******
Profit or Loss
*******
 129.97%
*******
*******
*******
*******
Net Worth
*******
 22.92%
*******
*******
*******
*******
EBITDA
*******
 109.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lustre Pharmaceuticals?

Unlock access to Lustre Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹68,937,000.00

Satisfied Charges

₹79,407,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 4.24 Cr
  • Others : 2.65 Cr
Latest Charge Details
Date Lender Amount Status
13 Aug 2025 Others ₹2.65 Cr Open
18 Nov 2024 Hdfc Bank Limited ₹2.00 Cr Open
24 Sep 2024 Hdfc Bank Limited ₹2.25 Cr Open
27 Jul 2022 Others ₹1.80 Cr Satisfied
10 Sep 2020 Others ₹1.09 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lustre Pharmaceuticals?

Unlock and access historical data on people associated with Lustre Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lustre Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lustre Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lustre Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Lustre Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 26.50 M with Charge ID 101140769 was registered on 13 Aug 2025. was completed.

  • Balance Sheet

    Progress on Lustre Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 19.95 M registered on 18 Nov 2024 with Charge ID 101004929 was modified on 25 Mar 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 22.49 M registered on 24 Sep 2024 with Charge ID 100978829 was modified on 26 Nov 2024. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 19.95 M with Charge ID 101004929 was registered on 18 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lustre Pharmaceuticals Private Limited?

The CIN of Lustre Pharmaceuticals Private Limited is U24231GJ2003PTC042154.

Where is Lustre Pharmaceuticals Private Limited headquartered?

Lustre Pharmaceuticals Private Limited is headquartered at 15, Barcelona Industrial Estate, Sardar Patel Ring Road, Odhav Circle, Od, Hav,, Ahmedabad, Gujarat, 382415.

When was Lustre Pharmaceuticals Private Limited incorporated?

Lustre Pharmaceuticals Private Limited was incorporated on 24 March 2003.

Who are the current directors of Lustre Pharmaceuticals Private Limited?

The current directors of Lustre Pharmaceuticals Private Limited are

What is the primary industry of Lustre Pharmaceuticals Private Limited?

The primary industry of Lustre Pharmaceuticals Private Limited is Manufacturing.

Is Lustre Pharmaceuticals Private Limited a listed company?

Lustre Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Lustre Pharmaceuticals Private Limited?

The authorized capital of Lustre Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Lustre Pharmaceuticals Private Limited?

The compliance status of Lustre Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available